Key facts
- PRICE T ROWE ASSOCIATES INC /MD/ filed SCHEDULE 13G/A for AVIDITY BIOSCIENCES INC COMMON STOCK (RNA).
- Disclosed ownership: 0.1%.
- Date of event: 31 Dec 2025.
PRICE T ROWE ASSOCIATES INC /MD/ - 31 Dec 2025 SCHEDULE 13G/A Report for AVIDITY BIOSCIENCES INC COMMON STOCK (RNA)
- Filing Manager
- PRICE T ROWE ASSOCIATES INC /MD/
- Reporting Manager
- T. Rowe Price Associates, Inc.
- Security
- AVIDITY BIOSCIENCES INC COMMON STOCK
- Symbol
- RNA
- Disclosed Ownership
- 142,888 shares
- Ownership
- 0.1%
- Form type
- SCHEDULE 13G/A
- Filing time
- 17 Feb 2026, 10:26:21 UTC
- Date of event
- 31 Dec 2025
- Previous filing
- 14 Nov 2025
- SEC
- View on sec.gov
Key filing fact
PRICE T ROWE ASSOCIATES INC /MD/ disclosed 0.1% ownership in AVIDITY BIOSCIENCES INC COMMON STOCK (RNA) on 31 Dec 2025.
Change
- Previous schedule filing date: 14 Nov 2025.
- Current filing was accepted on 17 Feb 2026, 10:26.
Research use
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Reporting managers (1)
Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| T. Rowe Price Associates, Inc. | 0.1% | 142,888 | 140,624 | 0 | Ellen York | Vice President |
CIK / CUSIP context first